Autoantibodies against bactericidal/permeability-increasing protein in cystic fibrosis patients: comment on the article by Hoffman and Specks.
Taccetti
G
G
Campana
S
S
Marianelli
L
L
Procopio
E
E
Turchini
S
S
D000293:Adolescent; D000328:Adult; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis*; D023181:Antimicrobial Cationic Peptides; D015415:Biomarkers / Q000032:analysis; D001798:Blood Proteins / Q000276:immunology*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008565:Membrane Proteins; D008875:Middle Aged; D053146:Myeloblastin; D009195:Peroxidase / Q000276:immunology; D012697:Serine Endopeptidases / Q000276:immunology
D019268:Antibodies, Antineutrophil Cytoplasmic; D023181:Antimicrobial Cationic Peptides; D015415:Biomarkers; D001798:Blood Proteins; D008565:Membrane Proteins; C021623:bactericidal permeability increasing protein; D002097:C-Reactive Protein; D009195:Peroxidase; D012697:Serine Endopeptidases; D053146:Myeloblastin